Newsroom

UneBragaEN
Vidéos

Back from the field Elizabeth Braga, physiotherapist was in Jahun, Nigeria, for the MSF Foundation.

UneEN1year
Vidéos
Antibiogo

1 year after its routine implementation, where does Antibiogo stand? Interview with Dr Nada Malou

Articles
Antibiogo

Antibiogo: facts and impacts in the fight against antimicrobial resistance

The World Health Organization's Global AMR Awareness Week is a worldwide campaign to raise awareness and understanding of the problem of antimicrobial resistance. To mark the occasion, here is a series of infographics to help you better understand the hope that Antibiogo, a new diagnostic tool holds for combating this threat on public health.

Read more
WPC Dubai 2023 fondation msf
Vidéos
Programme 3D

The MSF Foundation 3D program at the WPC World Physiotherapy Congress in Dubai

AI4CC qu'est-ce que c'est
Vidéos
AI4CC

AI4CC (Artificial intelligence for cervical cancer), what is it?

Publications
Étude Fièvre Jaune

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Read more
Publications
Étude Fièvre Jaune

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Read more

Headline

MSF
Articles

Palestine: MSF responds to the Israeli government's smear campaign

For several days, Médecins Sans Frontières and the MSF Foundation have been the target of an online smear campaign.

Keywords associated with our organizations have been misused in several countries to direct internet users to a disinformation website.

In this context, we are sharing MSF’s statement and reaffirming our commitment to continue our humanitarian work with the populations we support.

Read more

MSF Foundation in Video

News

Publications

  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.